Digoxin Antibodies

Santa Cruz Biotechnology offers a broad range of Digoxin Antibodies for various research applications. Digoxin Antibodies are validated for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Digoxin is a cardiac glycoside that plays a crucial role in the treatment of heart conditions, particularly atrial fibrillation and heart failure. It works by inhibiting the Na+/K+ ATPase pump, leading to increased intracellular calcium levels and enhanced cardiac contractility. Understanding the function and regulation of Digoxin is essential for optimizing therapeutic strategies and improving patient outcomes. Digoxin monoclonal antibodies enable precise detection and quantification in various experimental settings. Researchers can utilize specific conjugates including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for enhanced visualization and analysis. Santa Cruz Biotechnology monoclonal antibodies for Digoxin research support scientists worldwide in advancing cardiovascular medicine and improving patient care.